| Blackfeet Care Center | |
| 728 S Government Sq, Browning, Montana 59417 | |
| (406) 338-2686 | |
| Name | Blackfeet Care Center |
|---|---|
| Location | 728 S Government Sq, Browning, Montana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 47 |
| Occupancy Rate | 36.17% |
| Medicare ID (CCN) | 275133 |
| Legal Business Name | Legal Business Name Not Available |
| Ownership Type | Government - City/county |
| NPI Number | 1538248067 |
| Organization Name | BLACKFEET TRIBE |
| Doing Business As | BLACKFEET CARE CENTER, BLACKFEET NURSING HOME, BLACKFEET EXTENDED CARE |
| Address | South Government Square, South Government Square, Browning, MT 59417 |
| Phone Number | 406-338-2686 |
News Archive
A normally benign protein found in the human body appears to be able - when paired with nanoparticles - to zero in on and kill certain cancer cells, without having to also load those particles with chemotherapy drugs.The finding could lead to a new strategy for targeted cancer therapies, according to the University of North Carolina at Chapel Hill scientists who made the discovery.
Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, confirmed today the previously published findings from a head-to-head comparison study of its lead human cancer product Paclical and Celgene's Abraxane, demonstrated superimposable paclitaxel PK profiles. The study was conducted in women with metastatic breast cancer.
Former House Speaker Newt Gingrich (R-Ga.) on Monday at a health care symposium sponsored by Siemens said that the Bush administration and Congress should do more to implement electronic health records nationwide, the Baltimore Sun reports.
Researchers reported promising outcomes data for the first group of boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a fatal genetic immunodeficiency also known as "bubble boy" disease, who were treated as part of an international clinical study of a new form of gene therapy. The mechanism used to deliver the gene therapy is designed to prevent the serious complication of leukemia that arose a decade ago in a similar trial in Europe, when one-quarter of boys treated developed the blood cancer.
› Verified 3 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A normally benign protein found in the human body appears to be able - when paired with nanoparticles - to zero in on and kill certain cancer cells, without having to also load those particles with chemotherapy drugs.The finding could lead to a new strategy for targeted cancer therapies, according to the University of North Carolina at Chapel Hill scientists who made the discovery.
Oasmia Pharmaceutical AB, a developer of a new generation of drugs within human and veterinary oncology, confirmed today the previously published findings from a head-to-head comparison study of its lead human cancer product Paclical and Celgene's Abraxane, demonstrated superimposable paclitaxel PK profiles. The study was conducted in women with metastatic breast cancer.
Former House Speaker Newt Gingrich (R-Ga.) on Monday at a health care symposium sponsored by Siemens said that the Bush administration and Congress should do more to implement electronic health records nationwide, the Baltimore Sun reports.
Researchers reported promising outcomes data for the first group of boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a fatal genetic immunodeficiency also known as "bubble boy" disease, who were treated as part of an international clinical study of a new form of gene therapy. The mechanism used to deliver the gene therapy is designed to prevent the serious complication of leukemia that arose a decade ago in a similar trial in Europe, when one-quarter of boys treated developed the blood cancer.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 3 |
| Total Amount of Fines in Dollars | $160958 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 3 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25.93 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.94 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 44.44 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.18 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.13 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.45 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.13 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 81.25 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 3.13 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 69.57 | 83.88 |